Trial Profile
Open-label, uncontrolled trial to evaluate pharmacokinetics of naloxone in children from 4 to less than 18 years of age with opioid-induced constipation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2022
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Develco Pharma Schweiz
- 29 Apr 2018 This trial has been Suspended in Germany as per Eudra
- 09 Mar 2016 New trial record